Autolus Therapeutics (AUTL) Competitors

Vera Therapeutics (NASDAQ:VERA) and Autolus Therapeutics (NASDAQ:AUTL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.

Which has better valuation and earnings, VERA or AUTL?

Vera Therapeutics has higher earnings, but lower revenue than Autolus Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than Autolus Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vera Therapeutics	N/A	N/A	-$95.99M	-$3.00	-6.85
Autolus Therapeutics	$9.01M	45.63	-$208.38M	-$0.88	-1.76

Do insiders & institutionals hold more shares of VERA or AUTL?

99.2% of Vera Therapeutics shares are held by institutional investors. Comparatively, 72.8% of Autolus Therapeutics shares are held by institutional investors. 16.3% of Vera Therapeutics shares are held by insiders. Comparatively, 25.7% of Autolus Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community favor VERA or AUTL?

Autolus Therapeutics received 187 more outperform votes than Vera Therapeutics when rated by MarketBeat users. Likewise, 68.25% of users gave Autolus Therapeutics an outperform vote while only 66.15% of users gave Vera Therapeutics an outperform vote.

Company	Underperform	Outperform
Vera Therapeutics	Outperform Votes 43 66.15%	Underperform Votes 22 33.85%
Autolus Therapeutics	Outperform Votes 230 68.25%	Underperform Votes 107 31.75%

Is VERA or AUTL more profitable?

Vera Therapeutics' return on equity of -50.13% beat Autolus Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vera Therapeutics	N/A	-50.13%	-39.50%
Autolus Therapeutics	N/A	-63.65%	-36.54%

Does the media refer more to VERA or AUTL?

In the previous week, Vera Therapeutics had 11 more articles in the media than Autolus Therapeutics. MarketBeat recorded 15 mentions for Vera Therapeutics and 4 mentions for Autolus Therapeutics. Vera Therapeutics' average media sentiment score of 1.17 beat Autolus Therapeutics' score of 0.63 indicating that Vera Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vera Therapeutics	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Autolus Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, VERA or AUTL?

Vera Therapeutics has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Autolus Therapeutics has a beta of 1.77, suggesting that its share price is 77% more volatile than the S&P 500.

Do analysts rate VERA or AUTL?

Vera Therapeutics currently has a consensus target price of $63.33, indicating a potential upside of 208.34%. Autolus Therapeutics has a consensus target price of $9.32, indicating a potential upside of 503.24%. Given Autolus Therapeutics' higher possible upside, analysts clearly believe Autolus Therapeutics is more favorable than Vera Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vera Therapeutics	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.10
Autolus Therapeutics	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Autolus Therapeutics beats Vera Therapeutics on 9 of the 17 factors compared between the two stocks.